FPD/AML stands for familial platelet disorder with predisposition to acute myelogenous leukemia. FPD/AML is a pre-leukemic disorder involving an autosomal-dominant, inherited qualitative/quantitative defect of platelets associated with an approximately 50% lifetime risk of developing AML (an acute form of leukemia). Read more about RUNX1 FPD/AML »
The most affective known treatments are stem-cell or bone-marrow transplants. The Babich Family Foundation is committed to accelerating new and innovative research into treatments and cures.
Get answers to some frequently asked questions about RUNX1 FPD/AML.
An archive of our quarterly newsletters